Literature DB >> 6587730

Atenolol and metoprolol. A comparison of their excretion into human breast milk.

J Kulas, N O Lunell, U Rosing, B Stéen, A Rane.   

Abstract

The transfer of atenolol and metoprolol to human breast milk was studied in 7 lactating women with hypertension. Concentrations of atenolol and metoprolol in maternal plasma and milk and in plasma of the nursed infants were determined. Blood samples were obtained from the women and from the infants during a dose interval. Milk was collected repeatedly from the left breast but only twice from the right breast. The ratio between the area under the milk concentration versus time curve ( AUCm ) and the area under the plasma concentration versus time curve ( AUCp ) in the mother varied between 2.0 and 3.1 for metoprolol and 1.1 and 3.1 for atenolol. The milk concentrations of metoprolol in the right breast were similar to those in the left breast, although the latter had been emptied more frequently. For atenolol the milk concentrations in the right breast were lower than in the left breast. The plasma concentrations of metoprolol and atenolol in the infants were negligible or below the limit of detection. Our results show that exposure of the infant to metoprolol can be minimized if nursing is not undertaken earlier than 3-4 hours after dose intake.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6587730     DOI: 10.3109/00016348409157126

Source DB:  PubMed          Journal:  Acta Obstet Gynecol Scand Suppl        ISSN: 0300-8835


  16 in total

Review 1.  Atenolol. A reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders.

Authors:  A N Wadworth; D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

2.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

3.  Prediction of drug concentrations in human skim milk from plasma protein binding and acid-base characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Br J Clin Pharmacol       Date:  1988-04       Impact factor: 4.335

4.  Pharmacokinetics of metoprolol during pregnancy and lactation.

Authors:  Rachel J Ryu; Sara Eyal; Thomas R Easterling; Steve N Caritis; Raman Venkataraman; Gary Hankins; Erik Rytting; Kenneth Thummel; Edward J Kelly; Linda Risler; Brian Phillips; Matthew T Honaker; Danny D Shen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2015-12-04       Impact factor: 3.126

5.  Atenolol pharmacokinetics and excretion in breast milk during the first 6 to 8 months postpartum.

Authors:  Sara Eyal; Joong D Kim; Gail D Anderson; Megan L Buchanan; Debra A Brateng; Darcy Carr; David E Woodrum; Thomas R Easterling; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2010-02-09       Impact factor: 3.126

6.  Transfer of labetalol into amniotic fluid and breast milk in lactating women.

Authors:  N O Lunell; J Kulas; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

Review 7.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

8.  Amphetamine secretion in breast milk.

Authors:  E Steiner; T Villén; M Hallberg; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 9.  Breastfeeding and migraine drugs.

Authors:  Riccardo Davanzo; Jenny Bua; Giulia Paloni; Giulia Facchina
Journal:  Eur J Clin Pharmacol       Date:  2014-09-13       Impact factor: 2.953

Review 10.  The pharmacokinetics of antiarrhythmic agents in pregnancy and lactation.

Authors:  G M Mitani; I Steinberg; E J Lien; E C Harrison; U Elkayam
Journal:  Clin Pharmacokinet       Date:  1987-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.